ArticleInternational journal of clinical and experimental pathology2018
The expression pattern of fibroblast growth factor 10 and its receptors during buffalo follicular development.
Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Review
- Effects of Human Endothelial Progenitor Cell and Its Conditioned Medium on Oocyte Development and Subsequent Embryo Development.International journal of molecular sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explored the expression and localization of fibroblast growth factor (FGF) 10 and its receptors (FGF receptor 1 and FGF receptor 2, FGFR1 and FGFR2) during buffalo follicular development, laying a foundation for the further study of FGF signaling pathways in follicular development and oogenesis. Granulosa cells and ovarian follicles were extracted from buffalo ovaries, and in vitro maturation culture of oocytes was conducted. Immunohistochemistry was performed to detect the expression of FGF10 and its receptors FGFR1 and FGFR2. In addition, immunofluorescence staining was used to detect the expression of FGF10 in buffalo cumulus oocyte complexes (COCs). Moreover, mRNA levels of FGF10, sub-types of FGFR1 and FGFR2 (FGFR1b and FGFR2b) were measured using qRT-PCR. Immunohistochemistry results showed that FGF10 and its receptors FGFR1 and FGFR2 appeared to have positive responses in buffalo primordial follicles, primary follicles, secondary follicles, and mature follicle oocytes and granulosa cells, and mature follicle basal membrane cells. However, no expression of FGF10 mRNA was detected in granulosa cells from follicles of different diameters, but immunofluorescence results showed that FGF10 could be detected in both cumulus cells and oocytes. With an increase in the vitro maturation time of buffalo COCs, FGF10 and receptor sub-types FGFR1b and FGFR2b mRNA expression also gradually increased, and significantly higher than before maturation. In summary, FGF10 and its receptors may be involved in the process of buffalo follicular development and oocyte maturation.
Indexed as
Identifiers
31949569PMC6962906W3024924672What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.